FOI Request
- Disclosure ID
- FOI/02877
- Request Date
- December 21, 2018
- Subject
- Cancer Treatment And Brexit
- Description
I wish to see the risk assessments and any associated documents made for or by the nuclear medicine department in regards availability of cancer treatments over the period of Britain exiting the European Union and beyond. Please also supply any other relevant information.
- Response
In September 2018 a statement was released from the president of the BNMS (British Nuclear Medicine Society) advising NHS trusts to add this to the risk register as the highest priority.
Please see the attached risk assessment written in response to the uncertainty of Brexit and concerned with the future supply of radiopharmaceuticals XR232.